Imprimis Pharmaceuticals, Inc.

Aug 07, 2017

Imprimis Statement Regarding Curcumin Emulsion FDA MedWatch Notice

Jul 31, 2017

Imprimis Pharmaceuticals to Host its Second Quarter 2017 Financial Report Conference Call and Webcast on August 10, 2017 at 4:15 p.m. EDT

Jul 27, 2017

Imprimis Pharmaceuticals Patent-Pending Dropless and LessDrops Formulations Exceed One Million Patient Eyes Milestone

Jul 20, 2017

Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings

Jun 29, 2017

Imprimis Pharmaceuticals Sells Pennsylvania Facility and Sinus Assets

Jun 23, 2017

Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director

Jun 20, 2017

Eton Pharmaceuticals Announces $20 Million Series A Financing